announcements & circulars-凯发88
english
凯发88-凯发vip-娱乐凯发app下载
中文繁体
company
overview
board of directors
scientific advisory board
partnering
core competence
technology
bispecific
mix-mab
biologics manufacturing
publications
pipeline
overview
envafolimab(kn035)
kn046
kn026
kn026 kn046
kn019
investors
information disclosure
corporate governance
stock information
ir contacts
email subscription
news
press release
media report
career
corporate culture
job opportunities
contact us
company
overview
board of directors
scientific advisory board
partnering
core competence
technology
bispecific
mix-mab
biologics manufacturing
publications
pipeline
overview
envafolimab(kn035)
kn046
kn026
kn026 kn046
kn019
investors
information disclosure
corporate governance
stock information
ir contacts
email subscription
news
press release
media report
career
corporate culture
job opportunities
contact us
english
凯发88-凯发vip-娱乐凯发app下载
中文繁体
investors
information disclosure
listing documents
financial reports
announcements & circulars
company presentation
corporate governance
stock information
ir contacts
email subscription
announcements & circulars
the announcement begins in december 2019
date of board meeting
2020-03-18
monthly return of equity issuer on movements in securities for the month ended 29 february 2020
2020-03-04
voluntary announcement - four ind applications accepted by nmpa cde for two anti-tumor bisepecific antibodies in pipeline
2020-02-20
voluntary announcement - jiangsu alphamab passed on-site inspection of eu qualified person
2020-02-07
monthly return of equity issuer on movements in securities for the month ended 31 january 2020
2020-02-05
next day disclosure return
2020-01-08
monthly return of equity issuer on movements in securities for the month ended 31 december 2019
2020-01-06
full exercise of the over-allotment option, stabilizing actions and end of stabilization period
2020-01-05
inside information announcement – collaborative partnership agreement with tracon and 3dmed
2019-12-20
voluntary announcement - completion of construction of the phase i manufacturing facilities
2019-12-18
7
8
9
10
11
prev
10/11
next
网站地图